小児心臓胸部手術後の高流量鼻カニューラ

基本情報

NCT ID: NCT04451057
ステータス: 募集中
試験のフェーズ: 該当なし
試験タイプ: 介入
目標被験者数: 286
治験依頼者名: Osaka University

概要

High flow nasal cannula(HFNC) ventilation can provide such effects as wash-out effect of the carbon dioxide inside the anatomical dead space,some level of continuous airway pressure and humidified oxygen gases. Therefore because of its physiological benefits, it has been reported that HFNC can reduce "treatment failure" after extubation in pediatric patients like preterm babies,or infants who suffer from bronchitis. However there is no evidence showing that HFNC can reduce "treatment failure" after extubation in pediatric patients after cardiothoracic surgery. This multi-center randomized controlled trial (RCT) involving pediatric patients after cardiothoracic surgery will be conducted to determine whether HFNC,compared with conventional oxygen therapy,after extubation can reduce the rate of"escalation of care due to treatment failure".

対象疾患

Pediatric Patients After Cardiothoracic Surgery

介入

high flow nasal cannula therapy(DEVICE)

low flow nasal cannula therapy(DEVICE)

依頼者（Sponsor）

Hyogo Prefectural Kobe Children's Hospital(OTHER)

Osaka City General Hospital(OTHER)

National Center For Child Health And Development(UNKNOWN)

Aichi Children's Health And Medical Center(UNKNOWN)

Osaka Women's And Children's Hospital(UNKNOWN)

Osaka University(OTHER)

実施施設 (1)

大阪大学医学部附属病院

Osaka, Japan(RECRUITING)